Double Moving Average Crossover
Previous Close | 1.3800 |
Open | 1.4000 |
Bid | 1.2600 x 3100 |
Ask | 1.3900 x 1100 |
Day's Range | 1.3000 - 1.4252 |
52 Week Range | 1.1700 - 3.2600 |
Volume | |
Avg. Volume | 33,749 |
Market Cap | 12.099M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2800 |
Earnings Date | May 04, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.50 |
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group LLC (“Maxim”) and M-Vest, a division of Maxim, on Thursday, June 1, 2023. Ms. Curley will participate in a fireside chat with
Quarterly Revenue Increased 17% Year-Over-YearLEXINGTON, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three-month period ended March 31, 2023. “I am pleased to report that iSpecimen delivered strong revenue of approximately $3.0 million,
LEXINGTON, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Aegis Conference to be held virtually on May 2-4, 2023. Ms. Curley will present on Thursday, May 4, 2023, at 4:30 p.m. ET. To attend, please join here. For more
LEXINGTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the first quarter ended March 31, 2023 before the market opens on Thursday, May 4, 2023. The Company will host a conference call and audio webcast that morning at 8:30 a.m. Ea
iSpecimen Inc. ( NASDAQ:ISPC ) shares have had a really impressive month, gaining 33% after a shaky period beforehand...
iSpecimen Inc. (NASDAQ:ISPC) Q4 2022 Earnings Call Transcript March 14, 2023 Operator: Good day, everyone and welcome to iSpecimen’s Full Year 2022 Conference Call. At this time, participants will be in a listen-only mode. A question-and-answer session will follow managements’ remarks. This conference call is being recorded. A replay of today’s call will be available […]
- Reported Record Quarterly Revenue of $3.2 Million, Up 28% Year-Over-Year -LEXINGTON, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the twelve-month period ended December 31, 2022. “At the beginning of the fourth quarter of 2022, I steppe
Award Highlights Businesses at the Forefront of Innovation That Are Transforming Industries and Shaping SocietyLEXINGTON, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers (“iSpecimen”), has been named to Fast Company’s annual list of the World’s Most Innovative Companies as part of the biotech category for 2023. Fast Company is
LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2022, before the markets open on Tuesday, March 14, 2023. The Company will host a conference call and audio webcast that mor
iSpecimen Strategically Grows its Proprietary Marketplace Platform with Seven New Biospecimen Sample Providers Across the U.S. and EuropeLEXINGTON, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that over the course of the second half of 2022, the Company added and onboarded seve
NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 25th at 8:15 A.M. ET Maxim Group LLC presents the Healthcare IT Virtual Conference. Participating companies focus on technology addressing rising health care costs, and scarcity of wo
Mr. Langlois Led iSpecimen to 3,000 Percent Revenue Growth During His Tenure as the Company’s Former SVP of Sales and Business DevelopmentLEXINGTON, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that it appointed Eric Langlois as Chief Revenue Officer, effective immediately. Mr.
LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Sequire Biotechnology Conference to be held virtually on Thursday, February 2, 2023. Ms. Curley will present at 5:00 p.m. ET. To attend, please register here. Fo
LEXINGTON, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group and M-Vest on Wednesday, January 25, 2023. Ms. Curley will present at 8:30 a.m. ET. To attend, please regi
Previously Appointed Interim CEO in September 2022LEXINGTON, Mass., Jan. 10, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that its Board of Directors has appointed Tracy Curley, former Interim CEO, as CEO, effective immediately. “I am grateful to the Board and the entire team at iSpecimen for
Sought-After Strategic Advisor Brings Expertise in Mergers and Acquisitions, Restructuring and Governance to iSpecimenLEXINGTON, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that the Company has appointed Joseph J. Basile to iSpecimen’s Board of Directors (the “Board”), as well
- Reported Revenue of $2.6 Million, Comprised Of A Record 88% Non-COVID Revenue -LEXINGTON, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three- and nine-month period ended September 30, 2022. “During the third quarter of 2022, iSpecime
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
New Feature Provides Suppliers with Research Transparency to Optimize Fulfillment ProcessLEXINGTON, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that the Company has launched its new self-service Open Feasibilities Dashboard on iSpecimen Marketplace®, allowing supplier partners
LEXINGTON, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the third quarter ended September 30, 2022, before the markets open on Tuesday, November 8, 2022. The Company will host a conference call and audio webcast that morning at 8:30
Lexington, Massachusetts--(Newsfile Corp. - October 18, 2022) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, Interim CEO and CFO of iSpecimen, will present at the ThinkEquity Conference to be held at the Mandarin Oriental Hotel in New York City on October 26, 2022 at 4:30 p.m. ET. ...
New Program Designed to Support Provider Partners with Onsite CoordinatorLEXINGTON, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today launched its new Marketplace Onsite program to offer additional support to the Company’s biospecimen provider partners. The program embeds a coordinator at sel
Current President and CEO, Christopher Ianelli, to Leave CompanyLEXINGTON, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today the immediate appointment of Tracy Curley as interim CEO, replacing current Chief Executive Officer and President, Christopher Ianelli. In addition to servin
LEXINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on Septembe